Insider for issuer (KN) files to sell 25,000 common shares on NYSE

Rhea-AI Filing Summary

Form 144 discloses a planned sale of 25,000 shares of common stock through Morgan Stanley Smith Barney LLC on or about February 3, 2026, to be sold on the NYSE with an aggregate market value of $637,500.

The securities to be sold were acquired as performance shares from the issuer on February 8, 2021, in the same 25,000-share amount. The notice also lists prior sales by Jeffrey S. Niew over the past three months: 25,000 shares for $600,000 on December 10, 2025, 25,000 shares for $587,500 on December 4, 2025, and 50,000 shares for $1,237,500 on January 15, 2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	637500.00	85151884	02/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/08/2021	Performance Shares	ISSUER			25000	02/08/2021	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JEFFREY S NIEW 1151 Maplewood Drive, Itasca IL 60143	Common	12/10/2025	25000	600000.00
JEFFREY S NIEW 1151 Maplewood Drive, Itasca IL 60143	Common	12/04/2025	25000	587500.00
JEFFREY S NIEW 1151 Maplewood Drive, Itasca IL 60143	Common	01/15/2026	50000	1237500.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the KN Form 144 filing disclose?

The Form 144 filing reports a proposed sale of 25,000 shares of common stock on the NYSE with an aggregate market value of $637,500. It also details how these shares were acquired and lists the seller’s prior sales over the last three months.

How many KN shares are proposed to be sold under this Form 144?

The filing covers a proposed sale of 25,000 shares of common stock. These shares will be sold through Morgan Stanley Smith Barney LLC on or about February 3, 2026, under Rule 144 resale provisions for restricted or control securities.

Who is the selling security holder in the KN Form 144 notice?

The Form 144 identifies Jeffrey S. Niew as the person for whose account the securities are to be sold. His address is listed in the filing, and his recent sales of the issuer’s common shares over the past three months are also disclosed in detail.

What prior KN stock sales are reported in the last three months?

The filing lists three prior sales by Jeffrey S. Niew: 25,000 common shares for $600,000 on December 10, 2025, 25,000 shares for $587,500 on December 4, 2025, and 50,000 shares for $1,237,500 on January 15, 2026, all reported as gross proceeds.

How and when were the KN shares in this Form 144 acquired?

The 25,000 common shares covered by the notice were acquired on February 8, 2021, as performance shares from the issuer. The filing states the acquisition involved no special payment terms, describing the nature of payment simply as not applicable.

Which broker will handle the KN Form 144 stock sale?

The proposed sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s address is given as 1 New York Plaza, 8th Floor, New York, NY 10004, and the shares are expected to be sold on the NYSE marketplace.